Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 208

1.

Myelin changes in Alexander disease.

Gómez-Pinedo U, Duran-Moreno M, Sirerol-Piquer S, Matias-Guiu J.

Neurologia. 2017 Mar 22. pii: S0213-4853(17)30108-1. doi: 10.1016/j.nrl.2017.01.019. [Epub ahead of print] English, Spanish.

PMID:
28342553
2.

Glial Fibrillary Acidic Protein Exhibits Altered Turnover Kinetics in a Mouse Model of Alexander Disease.

Moody LR, Barrett-Wilt GA, Sussman MR, Messing A.

J Biol Chem. 2017 Feb 21. pii: jbc.M116.772020. doi: 10.1074/jbc.M116.772020. [Epub ahead of print]

3.

[An infant form of Alexander disease (a clinical case and literature review)].

Vasin RA, Krasnikov MA, Vasina SV.

Zh Vopr Neirokhir Im N N Burdenko. 2016;80(6):93-98. Russian.

PMID:
28139579
4.

Disorders of Astrocytes: Alexander Disease as a Model.

Olabarria M, Goldman JE.

Annu Rev Pathol. 2017 Jan 24;12:131-152. doi: 10.1146/annurev-pathol-052016-100218.

PMID:
28135564
5.

Alexander Disease.

Tavasoli A, Armangue T, Ho CY, Whitehead M, Bornhorst M, Rhee J, Hwang EI, Wells EM, Packer R, van der Knaap MS, Bugiani M, Vanderver A.

J Child Neurol. 2017 Feb;32(2):184-187. doi: 10.1177/0883073816673263. Epub 2016 Oct 10.

PMID:
28112050
6.

Atypical MRI features in familial adult onset Alexander disease: case report.

Liu Y, Zhou H, Wang H, Gong X, Zhou A, Zhao L, Li X, Zhang X.

BMC Neurol. 2016 Nov 4;16(1):211.

7.

Functional characterization of a GFAP variant of uncertain significance in an Alexander disease case within the setting of an individualized medicine clinic.

Boczek NJ, Sigafoos AN, Zimmermann MT, Maus RL, Cousin MA, Blackburn PR, Urrutia R, Clark KJ, Patterson MC, Wick MJ, Klee EW.

Clin Case Rep. 2016 Aug 15;4(9):885-95. doi: 10.1002/ccr3.655. eCollection 2016 Aug 15.

8.

Erratum to: Modeling Alexander disease with patient iPSCs reveals cellular and molecular pathology of astrocytes.

Kondo T, Funayama M, Miyake M, Tsukita K, Era T, Osaka H, Ayaki T, Takahashi R, Inoue H.

Acta Neuropathol Commun. 2016 Sep 16;4(1):101. No abstract available.

9.

Alexander disease - astrogliopathy considered as leukodystrophy - experience of an institution.

Mierzewska H, Mierzewska-Schmidt M, Salomons GS, Dudzińska M, Szczepanik E.

Dev Period Med. 2016 Apr-Jun;20(2):110-7.

PMID:
27442695
10.

Modeling Alexander disease with patient iPSCs reveals cellular and molecular pathology of astrocytes.

Kondo T, Funayama M, Miyake M, Tsukita K, Era T, Osaka H, Ayaki T, Takahashi R, Inoue H.

Acta Neuropathol Commun. 2016 Jul 11;4(1):69. doi: 10.1186/s40478-016-0337-0. Erratum in: Acta Neuropathol Commun. 2016;4(1):101.

11.

Teaching Video NeuroImages: Palatal tremor in adult-onset Alexander disease.

Sebesto JR, van Gerpen JA.

Neurology. 2016 Jun 14;86(24):e252. doi: 10.1212/WNL.0000000000002763. No abstract available.

PMID:
27298457
12.

Mapping of protein-protein interaction network of Alexander disease.

Saxena AK, Saxena VL, Dixit S.

Cell Mol Biol (Noisy-le-grand). 2016 May 30;62(6):17-21.

PMID:
27262796
13.

Composition of Rosenthal Fibers, the Protein Aggregate Hallmark of Alexander Disease.

Heaven MR, Flint D, Randall SM, Sosunov AA, Wilson L, Barnes S, Goldman JE, Muddiman DC, Brenner M.

J Proteome Res. 2016 Jul 1;15(7):2265-82. doi: 10.1021/acs.jproteome.6b00316. Epub 2016 Jun 2.

PMID:
27193225
14.

A novel GFAP mutation in a type II (late-onset) Alexander disease patient.

de Paiva AR, Freua F, Lucato LT, Parmera J, Dória D, Nóbrega PR, Olávio TR, Macedo-Souza LI, Kok F.

J Neurol. 2016 Apr;263(4):821-2. doi: 10.1007/s00415-016-8065-8. Epub 2016 Feb 25. No abstract available.

PMID:
26914930
15.

Unusual presentations and intrafamilial phenotypic variability in infantile onset Alexander disease.

Tonduti D, Ardissone A, Ceccherini I, Giaccone G, Farina L, Moroni I.

Neurol Sci. 2016 Jun;37(6):973-7. doi: 10.1007/s10072-015-2466-9. Epub 2016 Jan 7.

PMID:
26743065
16.

Alexander Disease: A Novel Mutation in GFAP Leading to Epilepsia Partialis Continua.

Bonthius DJ, Karacay B.

J Child Neurol. 2016 Jun;31(7):869-72. doi: 10.1177/0883073815624762. Epub 2015 Dec 29.

PMID:
26719496
17.

Nitric oxide mediates glial-induced neurodegeneration in Alexander disease.

Wang L, Hagemann TL, Kalwa H, Michel T, Messing A, Feany MB.

Nat Commun. 2015 Nov 26;6:8966. doi: 10.1038/ncomms9966.

18.

A canine orthologue of the human GFAP c.716G>A (p.Arg239His) variant causes Alexander disease in a Labrador retriever.

Van Poucke M, Martlé V, Van Brantegem L, Ducatelle R, Van Ham L, Bhatti S, Peelman LJ.

Eur J Hum Genet. 2016 Jun;24(6):852-6. doi: 10.1038/ejhg.2015.223. Epub 2015 Oct 21.

PMID:
26486469
19.

CSF and Blood Levels of GFAP in Alexander Disease(1,2,3).

Jany PL, Agosta GE, Benko WS, Eickhoff JC, Keller SR, Köehler W, Koeller D, Mar S, Naidu S, Marie Ness J, Pareyson D, Renaud DL, Salsano E, Schiffmann R, Simon J, Vanderver A, Eichler F, van der Knaap MS, Messing A.

eNeuro. 2015 Oct 1;2(5). pii: ENEURO.0080-15.2015. doi: 10.1523/ENEURO.0080-15.2015. eCollection 2015 Oct 1.

20.

Adult Alexander disease with de novo c.1193C>T heterozygous variant in GFAP gene.

Di Giovanni M, Poggiani A, Bianchi S, Rosini F, Rufa A, Federico A.

Neurol Sci. 2016 Jan;37(1):143-5. doi: 10.1007/s10072-015-2378-8. Epub 2015 Sep 22. No abstract available.

PMID:
26396075

Supplemental Content

Loading ...
Support Center